Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice.

Hidenori ToyodaJennifer LeongCharles LandisMasanori AtsukawaTsunamasa WatanabeDaniel Q HuangJoanne LiuSabrina Xin Zi QuekToru IshikawaTaeang AraiKeisuke YokohamaMakoto ChumaKoichi TakaguchiHaruki UojimaTomonori SenooHansen DangMayumi MaedaJoseph HoangRichard H LeSatoshi YasudaKhin N ThinSally TranNicholas ChienLinda HenryAkira AsaiShinya FukunishiRamsey CheungSeng Gee LimHuy N TrinhMindie H Nguyen

Published in: Hepatology (Baltimore, Md.) (2021)

Overall, we observed continued improvement in virologic response, ALT normalization, and no significant changes in eGFR following switch to TAF from TDF.

Keyphrases

antiretroviral therapy
small cell lung cancer
primary care
healthcare
epidermal growth factor receptor
tyrosine kinase
clinical practice
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
weight loss
replacement therapy